DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING HPTLC METHOD FOR THE ESTIMATION OF PERINDOPRIL AND INDAPAMIDE by Bhoir, Varsha et al.
Sutar et al. 
Int J Pharm Pharm Sci, Vol 6, Issue 7, 621-625 
 
 
DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING HPTLC METHOD FOR THE 
ESTIMATION OF PERINDOPRIL AND INDAPAMIDE 
Original Article 
 
VARSHA BHOIR1, VIRAJ HIBARE, MRINALINI C. DAMLE* 
1Department of Quality Assurance, AISSMS College of Pharmacy, Pune, India, 2
Received: 19 Aug 2013 Revised and Accepted: 22 Sep 2013 
Department of Pharmaceutical Chemistry, AISSMS College of 
Pharmacy, Kennedy road, Near RTO, Pune 411001, Maharashtra, India. 
Email: mcdamle@rediffmail.com 
ABSTRACT  
Objective: To develop a validated stability indicating HPTLC method for determination Perindopril and Indapamide. 
Methods: The method was based on the separation of two drugs on plates precoated with silica gel 60 F254
Results: The optimized chromatographic conditions gave compact spot for Perindopril and Indapamide at Rf value of 0.30 ± 0.02 and 0.60 ± 0.02 
respectively. The calibration curve was found to be linear in range of 1000-5000 ng/band and 200-1000 ng/band for perindopril and indapamide 
respectively. The limit of detection and quantification were found to 164 ng/band and 491 ng/band for Perindopril and 41.41 ng/band and 
125.49ng/band for Indapamide. The method has been successfully applied to tablets and was validated according to ICH Harmonized Tripartite 
guidelines.  
 using Dichloromethane: Methanol: 
Glacial acetic acid in the ratio of 9.5:0.5:0.1 v/v/v as mobile phase followed by scanning in absorbance mode at 215 nm. 
Conclusion: A new sensitive, simple, rapid and precise high performance thin layer chromatographic (HPTLC) method has been developed and 
validated for simultaneous determination of Perindopril and Indapamide in pharmaceutical dosage form. The proposed method can be applicable 
for simultaneous determination of Perindopril and Indapamide in bulk and formulation. 
Keywords: Perindopril arginine, Indapamide, HPTLC, Stability indicating method. 
 
INTRODUCTION 
Perindopril arginine; (2S,3aS,7aS)-1-[(S)-N-[(S)-1-carboxybutyl] 
alanyl] hexahydro-2-indoline carboxylic acid 1-ethyl ester, is one of 
the non-peptide Angiotensin II receptor antagonists, and is used for 
the treatment of patients with hypertension and symptomatic heart 
failure.[1] Indapamide; 3-(aminosulfonyl)-4-chloro-N-(2,3-dihidro-
2-methyl-1H-indol-1-yl) benzamide, is a diuretic of the class of 
Benzothiadiazines. The combined oral administration of perindopril 
with indapamide has been found to be more effective than either of 
the drugs alone in the treatment of hypertension. Structures of 
Perindopril arginine and Indapamide are shown in Figure 1. A 
literature survey revealed that Perindopril arginine is official in the 
British Pharmacopoeia[2], Indapamide is official in the British 
Pharmacopoeia[3]. However, the combination is not official in any 
pharmacopeia. Upon detailed literature survey it was found that, 
individually these drugs have been analyzed by many methods[4-
11], however very few methods viz. one spectrophotometric 
method, two HPLC methods and one stability indicating RP-HPLC 
method has been reported for this combination.[12-14] To the best 
of our knowledge, no stability indicating HPTLC (High Performance 
Thin Layer Chromatography) method has been reported for 
simultaneous estimation of both the drugs in tablet dosage form. 
The present work describes the simple, accurate, precise, sensitive 
stability indicating HPTLC method for the determination of 
Perindopril arginine and Indapamide in combination. The method 
was validated as per the ICH guidelines.[15] 
 
Fig. 1: Structure of Perindopril Arginine and Indapamide 
MATERIALS AND METHODS  
Chemicals and Reagents  
Perindopril arginine and Indapamide was provided as a gift sample 
by Mylan Laboratories, Hyderabad. Methanol (AR grade), 
Dichloromethane (AR grade) and Glacial acetic acid (AR grade) were 
purchased from S. D. fine chemical Laboratories, Mumbai, India 
Instruments and Chromatographic conditions  
Chromatographic separation of drugs was performed on precoated 
silica gel 60 F254
After chromatographic development, bands were scanned over the 
range of 200-400 nm and the overlain spectra were obtained. Both 
the drugs showed considerable absorbance at 215 nm. So, 215 nm 
was selected as the detection wavelength (Figure 2). 
, (10 cm × 10 cm with 250 λ m layer thickness) 
purchased from E-Merck, Darmstadt, Germany. Samples were 
applied on the plate as a band with 4 mm width using Camag 100 µl 
sample syringe (Hamilton, Switzerland) with a Linomat 5 applicator 
(Camag, Switzerland). Linear ascending development was carried 
out in a twin trough glass chamber (for 10 x 10 cm) and a 
densitometric scanning was performed using Camag TLC scanner 3 
in the range of 400-200 nm, operated by winCATS software (Version 
1.4.3, Camag). Chamber saturation time was 15 min. Migration 
distance was 90 mm, slit dimensions were 3.00 x 0.45 mm and 
Deuterium lamp was used as a radiation source. 
Marketed Formulation 
A commercial pharmaceutical preparation, COVERSYL PLUS (Serdia 
Pharmaceuticals Pvt. Ltd., Mumbai, India) was assayed. Its label 
claim was as follows: 
Each uncoated scored tablet contains: 
PERINDOPRIL ARGININE B.P……………………… 4 mg 
INDAPAMIDE U.S.P…………………………….......... 1.25 mg  
Selection of wavelength  
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Fig. 2: Overlain spectra of Perindopril arginine and Indapamide. 
 
Method Development  
Method development for resolution of Perindopril arginine and 
Indapamide was started with the development of densitogram with 
solvents in different ratios and combinations of Toluene, Ethyl 
acetate, Methanol, Dichloromethane, Triethylamine, and Glacial 
acetic acid. Finally, Dichloromethane: Methanol: Glacial Acetic acid 
(9.5:0.5:0.1 v/v/v) was selected as a mobile phase with a good 
resolution at Rf 0.30 and 0.60 for Perindopril arginine and 
Indapamide respectively.  
Preparation of Stock and Standard Solutions  
Standard stock solutions of Perindopril arginine and Indapamide 
were prepared by separately dissolving 10 mg of drug in 10 ml of 
methanol to get concentrations of 1000 μg/ml. From the resultant 
solution of Perindopril, 1, 2, 3, 4 and 5 µl were applied on 5 X 10 cm 
pre-coated TLC plate as a band of length 4 mm, at a distance of 10 
mm from both x-axis and y-axis. 1 ml of standard stock solution of 
Indapamide was diluted to 10 ml with methanol in 10 ml volumetric 
flask to get working standard solution 100 μg/ml.  
From the resultant solution, 2, 4, 6, 8, and 10 µl were spotted on the 
plate. Plate was then developed in Camag 10 X 10 cm development 
chamber using selected mobile phase.  
Stress degradation studies of bulk drug 
Stress degradation studies were carried under condition of acid/ 
base/ neutral hydrolysis, oxidation, dry heat and photolysis. For 
each study, samples were prepared: the blank subjected to stress in 
the same manner as the drug solution, working standard solution of 
Indapamide subjected to stress condition, working standard solution 
of Perindopril subjected to stress degradation. Dry heat and 
photolytic degradation were carried out in solid state.  
Alkaline hydrolysis 
2 ml of solution of Indapamide was mixed with 2 ml of 0.1N NaOH. 
The solution was diluted to 10 ml with methanol and kept for 90 
min. 6 µl of the solution was spotted. 10 times higher concentration 
were also spotted to locate degradation product, if any. Same 
procedure was repeated for working standard solution of 
Perindopril with 0.01N NaOH, and spotted immediately.  
First the degradation was tried with 0.1N NaOH for half hour 
reduced to 0.01 N NaOH for 15mins. Degradation observed was too 
high. After addition of base in the standard solution of Perindopril, 
exothermic reaction was observed. So finally 0.01 NaOH was used 
for the degradation.  
Acidic hydrolysis 
2 ml of solution of Indapamide was mixed with 2 ml of 0.1 N HCl. 
The solution was diluted to 10 ml with methanol and kept for 90 
min. 2 µl of the solution was spotted. 10 times higher concentration 
were also spotted to locate degradation product, if any. Same 
procedure was repeated for working standard solution of 
Perindopril with 0.1N HCL after 15min. 
Neutral Hydrolysis 
2 ml of solution of Indapamide was mixed with 2 ml water. The 
solution was diluted to 10 ml with methanol and kept for 48 Hrs. 6 
µl of the solution was spotted. 10 times higher concentration were 
also spotted to locate degradation product, if any. Same procedure 
was repeated for working standard solution of Perindopril and was 
spotted immediately after exposure to neutral condition. 
Oxidation hydrolysis 
2 ml of solution of Indapamide was mixed with 2 ml 3% solution of 
H2O2
Degradation under dry heat 
. The solution was diluted to 10 ml with methanol and was kept 
for 48 Hrs. 6µl of the solution was spotted. 10 times higher 
concentration were also spotted to locate degradation product, if 
any. Same procedure was repeated for working standard solution of 
and Perindopril spotted immediately after exposure to oxidative 
condition. 
Dry heat studies were performed by keeping drug sample of 
Indapamide in oven (800 C) for a period of 24 hours. Samples were 
withdrawn after 24hrs, dissolved in methanol and diluted to get 
10µg/ml as final concentration of 6µl was spotted. 10 times higher 
concentration were also spotted to locate degradation product, if 
any. Perindopril was exposed to 400
Photo-degradation studies 
c for 15min and solution was 
prepared as above. First the degradation was tried for half hour but 
the degradation observed was high. The storage is strictly 
recommended in cold condition. 
Photolytic studies were also carried out by exposure of drug to UV 
light up to 200 watt hours/square meter and subsequently to cool 
fluorescent light to achieve an illumination of 1.2 million Lux.Hr. 
Samples were weighed, dissolved and diluted to get 10 µg/ml. 6µl of 
this solution was spotted. 10 times higher concentration was also 
spotted to locate degradation product, if any. Same procedure was 
followed for Perindopril.  
Preparation of Tablet solution for Assay  
10 tablets were accurately weighed and powdered. From the 
powdered mixture, certain amount (equivalent to 4 mg of 
perindopril arginine and 1.25 mg of Indapamide) of the powder was 
accurately weighed and transferred to 10 ml volumetric flask. 
Methanol was added in the volumetric flask and the resultant 
mixture was sonicated for 10 min at room temperature to disperse 
the powder completely. The resultant mixture was further diluted to 
10 ml with methanol and then filtered through Whatmann filter 
paper no 1, to get the clear solution. 1 ml aliquot of the filtered 
solution was then diluted to 10 ml with methanol in 10 ml 
volumetric flask to get the final concentration 100 μg/ml of 
Indapamide separately. 3 µl of 1000 μg/ml and 6µl of 100 μg/ml of 
this solution was spotted on TLC plate as a band of length 4 mm on 
two separate tracks for the assay of Perindopril arginine and 
Indapamide respectively.  
Method Validation  
Linearity and Range  
Linearity was studied by analyzing five concentrations of the drug, 
and process was repeated for five times each. It was done over the 
concentration range of 1000-5000 ng/band and 200-1000 ng/band 
for perindopril arginine and Indapamide respectively.  
Precision  
Precision of the system and method was evaluated by analyzing 
independent sample preparations obtained from homogenous 
sample and % RSD value obtained was calculated to determine any 
variation.  
Accuracy  
To check accuracy of the method, recovery studies were carried out 
by addition of standard drug solution to pre-analyzed sample 
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solution at three different levels of 80, 100 and 120 %. Mean 
percentage recovery for both the drugs was then determined.  
Limit of detection and limit of quantitation  
The detection limit of an individual analytical procedure is the 
lowest amount of analyte in a sample, which can be detected but not 
necessarily quantitated as an exact value.  
Specificity  
The specificity of the method was ascertained by peak purity 
profiling studies. Purity of the drug peak was ascertained by 
analyzing the spectrum at peak start, middle and at peak end. The 
peak purity was determined on TLC scanner 3 in the range of 200-
400 nm using WinCats software (version 1.4.3).  
Robustness  
The robustness of an analytical procedure is a measure of its 
capacity to remain  
unaffected by small, but deliberate variations in method parameters 
and provides an indication of its reliability during normal usage. 
Robustness of the method was determined by making slight 
deliberate changes like chamber saturation time and ± 2% variation 
in mobile phase compositions.  
RESULTS AND DISCUSSION  
Optimization of mobile phase  
TLC procedure was optimized with a view to develop a method for 
simultaneous estimation of Perindopril arginine and Indapamide. 
The drug reference standards were spotted on TLC plates and 
developed in different solvent systems. Different mobile phases 
were tried to resolve the peaks of Perindopril arginine and 
Indapamide. Best suited mobile phase was found to be 
Dichloromethane: Methanol: Glacial Acetic Acid in the ratio of 
9.5:0.5:0.1 v/v/v. Developed mobile phase resulted in resolution of 
Perindopril arginine and Indapamide at Rf 0.30 ± 0.02 and 0.60 ± 
0.02 respectively. Well-defined bands were obtained when the 
chamber was saturated for 15 min. with the mobile phase at room 
temperature before chromatographic development. (Figure 3) 
 
 
Fig. 3: Representative Densitogram of Perindopril arginine (Rf 
0.30 ± 0.02) and Indapamide (Rf 0.60 ± 0.02) 
 
Stress degradation study 
Hydrolysis at basic pH 
After alkaline degradation, 71.21% Indapamide was recovered with 
1 peak of degradation product. (Figure 3 A, B and C) While no 








Fig. 3: A) Blank NaOH, B) Indapamide (600ng/band) treated 
with NaOH, C) Overlain spectra of Indapamide and product of 
degradation. 
 
Hydrolysis at acidic pH 
After acid hydrolysis, 70.71% Indapamide was recovered with 1 
peak of degraded product while 77.36% Perindopril was recovered 
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Fig. 4: A) Blank HCL, B) Indapamide (600ng/band) treated with 
HCL, C) Overlain spectra of Indapamide and product of 
degradation. 
 
Under neutral hydrolysis 
After neutral hydrolysis, 71.94% Indapamide was recovered and 
65.66% Perindopril was recovered.  
After oxidative condition 
After oxidation, 74.34% Indapamide was recovered while 60.23% 
Perindopril was recovered with no peak of degraded product.  
 













1 Base (0.1 N NaOH, 
kept for 90 mins) 
4682 71.21 0.20 
2 Acid (0.1 N HCl, 
kept for 90 mins) 
4658 70.71 0.28 
3 Water 
(kept for 48 hrs.) 
4718 71.94 - 
4 H2O2 4835 3% 
(kept for 48 hrs) 
74.34 - 
5 Heat dry 
(800
5696 
C, 24 hrs.) 
91.99 - 
6. Photo stability 
[UV, 200 watt 
hrs/square meter 
Florescence, 1.2 











After the photo degradation 
After the photo degradation study for UV light and Fluorescence 
light, 100.01% Indapamide was recovered with no peak of 
degradation while 83.49% Perindopril with no peak of degradation.  
Degradation under dry heat 
After dry heat, 91.99% Indapamide was recovered with no peak of 
degraded product while 67.79% Perindopril was recovered with no 
peak of degraded product. 
Stress degradation results are summarized in Table 1 and 2 & 
results of method validation are given in Table 3. 
 













1 Base (0.01 N NaOH, 
immediately) 
2963 58.08 - 
2 Acid (0.1 N HCl, 
kept for 15mins) 
3752 77.36 - 
3 Water 
(immediately) 
3267 65.66 - 
4 H2O2 3072 3% 
(immediately) 
60.23 - 
5 Heat dry 
(400
3354 
C, 15 min) 
67.79 - 
6 Photo stability 
UV, 200 watt 
hrs/square meter 
Fluorescence, 1.2 











Method Validation  
The linearity in the proposed HPTLC method for determination of 
Perindopril arginine and Indapamide was found in the concentration 
range of 1000-5000 ng/band and 200-1000 ng/band with r2 value 
of 0.991 and 0.998 respectively (Figure 5).  
 
 
Fig. 5: Linearity for Perindopril Arginine (Rf 0.30 ± 0.02) and 
Indapamide (Rf 0.60 ± 0.02). 
 
Marketed sample of tablet was analyzed and the percentage label 
claim was found to be 99.98 % and 99.94 % for Perindopril arginine 
and Indapamide respectively. HPTLC method was validated as per 
the ICH guidelines. The accuracy of method was determined at 80, 
100 and 120 % level. The % recovery was found to be within the 
limits of 98 % to 102 % for both the drugs. Precision was calculated 
as interday and intraday variations. For System and Method 
precision, % RSD (Relative Standard Deviation) was found to be not 
more than 2 % for both drugs. For robustness studies, there were no 
significant changes in Rf and peak areas, which demonstrated that 
the developed HPTLC method is robust. Peak purity was found to be 
more than 0.995, which demonstrated that the method is specific. 
The results of validation are summarized in Table 3. 
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Table 3: Summary of validation parameters 
S.  No.  Validation Parameter  Results 
Indapamide Perindopril  
1.  Linearity  y = 8.128x + 1210 
(R2 = 
y = 1.363x + 588.7 
0.998) (R2= 0.991) 
2.  Range  200-1000 ng/band 1000-5000 ng/band 
3.  Precision  (%RSD) (%RSD)  
A) System precision  1.83  1.75 
A) Method precision  1.13 1.56 
4.  Accuracy  % Recovery  % Recovery  
80%  99.53 99.63 
100%  98.70 101.25 
120%  99.48 99.28 
5.  LOD  41.41 ng/band  164 ng/band 
6.  LOQ  125.49 ng/band 491 ng/band 
7.  Specificity  Specific  Specific  
8.  Robustness  Robust  Robust  
 
The degradation conditions mentioned above were arrived at, after 
number of initial trials for optimization of extent of degradation. 
Overall study comprised of stability indicating method development 
for Indapamide and Perindopril arginine. This method can be used 
for stability testing of this drug in dosage forms.  
CONCLUSION  
The validated HPTLC method was found to be simple, accurate and 
rapid for the routine determination of Perindopril arginine and 
Indapamide in tablet formulation. The proposed method can 
therefore, be successfully used for simultaneous estimation of 
Perindopril arginine and Indapamide in combined dosage form.  
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